Kiyatec specializes in providing advanced, 3D cell-based assays and diagnostics with superior physiologic relevance for more accurate ex vivo prediction of patient response to drugs. Kiyatec’s Greenville, South Carolina offices and labs are located in the heart of downtown, and closely collaborate with the Institute for Translational Oncology Research (ITOR) Clinical Research Unit on the main campus of the Greenville Health System, the 13th largest public hospital system in the United States. Kiyatec utilizes primary sourced cells and tissues directly from patients, to provide valuable data and insight to meet the needs of the pharmaceutical, biotechnology and healthcare industries. This information is becoming more vital, as Kiyatec is working to close the translational gap from preclinical to clinical by utilizing immunoassays, imaging, and other analytical capabilities on careful designed, proprietary spheroids.

Kiyatec is continuing to develop robust phenotypic cell-based cancer diagnostics using viable tumor biopsies to assess patient-specific response to available therapeutic agents. By leveraging Kiyatec’s specialized expertise and clinical connectivity, we add significant value to our clients’ preclinical, adaptive or co-clinical trials, and post-approval small molecule and biologic programs. Our technologies and methods provide more accurate simulation of phenomenon inherent within the living systems of the human body. Accurate modeling of these dynamic conditions creates opportunity for enhanced diagnostics and advanced medical treatments that will benefit society through the resulting improvements in healthcare and its associated costs.